Verapamil and risk of cancer in patients with coronary artery disease. DAVIT Study Group. Danish Verapamil Infarction Trial

A Sajadieh; H H Storm; J F Hansen

doi:10.1016/s0002-9149(99)00113-7

Verapamil and risk of cancer in patients with coronary artery disease. DAVIT Study Group. Danish Verapamil Infarction Trial

A Sajadieh
, H H Storm
, J F Hansen

Hjerteafdelingen BFH

15 Citationer (Scopus)

Abstract

The risk of cancer in users of verapamil was assessed in a long-term follow-up of 1,775 patients who were randomized to verapamil or matching placebo in the Danish Verapamil Infarction Trial-II in the years 1985 to 1987. During 10,474 patient-years, no increased risk of cancer was observed for the verapamil-treated men or women compared with the age- and sex-matched background population.

Originalsprog	Engelsk
Tidsskrift	The American journal of cardiology
Vol/bind	83
Udgave nummer	9
Sider (fra-til)	1419-22, A9
ISSN	0002-9149
DOI	https://doi.org/10.1016/s0002-9149(99)00113-7
Status	Udgivet - 1 maj 1999

Adgang til dokumentet

10.1016/s0002-9149(99)00113-7

Citationsformater

@article{e09f2524845745ec996c72e8a75375dd,

title = "Verapamil and risk of cancer in patients with coronary artery disease. DAVIT Study Group. Danish Verapamil Infarction Trial",

abstract = "The risk of cancer in users of verapamil was assessed in a long-term follow-up of 1,775 patients who were randomized to verapamil or matching placebo in the Danish Verapamil Infarction Trial-II in the years 1985 to 1987. During 10,474 patient-years, no increased risk of cancer was observed for the verapamil-treated men or women compared with the age- and sex-matched background population.",

keywords = "Aged, Calcium Channel Blockers/adverse effects, Coronary Disease/drug therapy, Female, Humans, Male, Middle Aged, Neoplasms/chemically induced, Randomized Controlled Trials as Topic, Risk, Verapamil/adverse effects",

author = "A Sajadieh and Storm, \{H H\} and Hansen, \{J F\}",

year = "1999",

month = may,

day = "1",

doi = "10.1016/s0002-9149(99)00113-7",

language = "English",

volume = "83",

pages = "1419--22, A9",

journal = "The American journal of cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "9",

}

TY - JOUR

T1 - Verapamil and risk of cancer in patients with coronary artery disease. DAVIT Study Group. Danish Verapamil Infarction Trial

AU - Sajadieh, A

AU - Storm, H H

AU - Hansen, J F

PY - 1999/5/1

Y1 - 1999/5/1

N2 - The risk of cancer in users of verapamil was assessed in a long-term follow-up of 1,775 patients who were randomized to verapamil or matching placebo in the Danish Verapamil Infarction Trial-II in the years 1985 to 1987. During 10,474 patient-years, no increased risk of cancer was observed for the verapamil-treated men or women compared with the age- and sex-matched background population.

AB - The risk of cancer in users of verapamil was assessed in a long-term follow-up of 1,775 patients who were randomized to verapamil or matching placebo in the Danish Verapamil Infarction Trial-II in the years 1985 to 1987. During 10,474 patient-years, no increased risk of cancer was observed for the verapamil-treated men or women compared with the age- and sex-matched background population.

KW - Aged

KW - Calcium Channel Blockers/adverse effects

KW - Coronary Disease/drug therapy

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Neoplasms/chemically induced

KW - Randomized Controlled Trials as Topic

KW - Risk

KW - Verapamil/adverse effects

U2 - 10.1016/s0002-9149(99)00113-7

DO - 10.1016/s0002-9149(99)00113-7

M3 - Journal article

C2 - 10235108

SN - 0002-9149

VL - 83

SP - 1419-22, A9

JO - The American journal of cardiology

JF - The American journal of cardiology

IS - 9

ER -

Verapamil and risk of cancer in patients with coronary artery disease. DAVIT Study Group. Danish Verapamil Infarction Trial

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater